Back
Emergent BioSolutions 10K Form
Buy
59
EBS
Emergent BioSolutions
Last Price:
$6.63
Seasonality Move:
6.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2023-12-11 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2023-08-09 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2023-05-10 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2022-11-09 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2022-08-02 | 10Q | EBS/Emergent BioSolutions Quarterly |
Receive EBS News And Ratings
See the #1 stock for the next 7 days that we like better than EBS
EBS Financial Statistics
Sales & Book Value
| Annual Sales: | $1B |
|---|---|
| Cash Flow: | $-14.8M |
| Price / Cash Flow: | 3.86 |
| Annual Sales: | $10.14 |
| Price / Book: | 0.65 |
Profitability
| EPS (TTM): | -2.71000 |
|---|---|
| Net Income (TTM): | $-131.6M |
| Gross Margin: | $332.3M |
| Return on Equity: | -25.37% |
| Return on Assets: | -8.65% |
Emergent BioSolutions Earnings Forecast
Key Emergent BioSolutions Financial Ratios
-
The Gross Profit Margin over the past 23 years for EBS is 32.78%.
-
The Selling, General & Administrative Expenses for EBS have been equal to 30.39% of Gross Profit Margin.
-
The Research & Development expenses have been 6.98% of Revenue.
-
The Net Earning history of EBS is -18.80% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 13 years.
Emergent BioSolutions Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | EBS |
| CUSIP: | 29089Q |
| Website: | emergentbiosolutions.com |
Debt
| Debt-to-Equity Ratio: | 1.2 |
|---|---|
| Current Ratio: | 6.32 |
| Quick Ratio: | 3.15 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 3.58 |
EBS Technical Analysis vs Fundamental Analysis
Buy
59
Emergent BioSolutions (EBS)
is a Buy
Is Emergent BioSolutions a Buy or a Sell?
-
Emergent BioSolutions stock is rated a BuyThe current Emergent BioSolutions [EBS] share price is $6.63. The Score for EBS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.